Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carcinoma, Hepatocellular"" wg kryterium: Temat


Tytuł:
Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model.
Autorzy:
Guo R; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China.
Lu F; Department of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Lin J; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, People's Republic of China.
Fu C; MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd, Shenzhen, 518057, People's Republic of China.
Liu M; MR scientific Marketing, Diagnostic Imaging, Siemens Healthineers Ltd, Shanghai, 201318, People's Republic of China.
Yang S; Department of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Middle Zhi-jiang Road, Shanghai, 200071, People's Republic of China. caddie_.
Pokaż więcej
Źródło:
European radiology experimental [Eur Radiol Exp] 2024 Mar 12; Vol. 8 (1), pp. 43. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/drug therapy
Bufanolides*
Humans ; Animals ; Mice ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Mice, Nude
Czasopismo naukowe
Tytuł:
Quantitative diffusion weighted imaging in patients with hepatocellular carcinoma: effects of simultaneous multi-slice acceleration and gadoxetic acid administration.
Autorzy:
Yang T; Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.
Ye Z; Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.
Yao S; Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.
Wu Y; Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.
Yin T; MR Collaborations, Siemens Healthineers Ltd, Chengdu, China.
Song B; Department of Radiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China. songlab_.; Department of Radiology, Sanya People's Hospital, Sanya, Hainan, China. songlab_.
Pokaż więcej
Źródło:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2024 Mar; Vol. 49 (3), pp. 683-693. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/pathology
Gadolinium DTPA*
Male ; Humans ; Female ; Adult ; Middle Aged ; Aged ; Prospective Studies ; Diffusion Magnetic Resonance Imaging/methods ; Acceleration ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Autorzy:
Long H; Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhong Shan Road 2, Guangzhou, 510080, China.
Zhou X; Department of Ultrasound, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Zhang X; Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhong Shan Road 2, Guangzhou, 510080, China.
Ye J; Division of Interventional Ultrasound, Department of Medical Ultrasonics, Foshan First People's Hospital, 81 Lingnan North Road, Foshan, 528000, Guangdong, China.
Huang T; Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhong Shan Road 2, Guangzhou, 510080, China.
Cong L; Medical Imaging System Division, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Shenzhen, China.
Xie X; Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhong Shan Road 2, Guangzhou, 510080, China. .
Huang G; Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhong Shan Road 2, Guangzhou, 510080, China. .; Department of Medical Ultrasonics, Guangxi Hospital Division of the First Affiliated Hospital, Sun Yat-Sen University, Guangxi, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Feb; Vol. 34 (2), pp. 1247-1257. Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Radiofrequency Ablation*/methods
Catheter Ablation*/methods
Humans ; Contrast Media ; Imaging, Three-Dimensional/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy.
Autorzy:
Stocker D; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. .
King MJ; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Homsi ME; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gnerre J; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marinelli B; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wurnig M; Institute of Radiology, Spital Lachen AG, Lachen, Switzerland.
Schwartz M; Recanati Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kim E; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Taouli B; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 475-484. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/radiotherapy
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/radiotherapy
Liver Neoplasms*/surgery
Humans ; Aged ; Retrospective Studies ; Pneumonectomy ; Magnetic Resonance Imaging/methods ; Sensitivity and Specificity ; Contrast Media
Czasopismo naukowe
Tytuł:
Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Autorzy:
Cha DI; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kang TW; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Jeong WK; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Joh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yi NJ; Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ahn SH; Department of Mathematics, Ajou University, Suwon, Republic of Korea.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 498-508. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Transplantation*
Gadolinium DTPA*
Male ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Magnetic Resonance Imaging ; Retrospective Studies ; Prognosis ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Tytuł:
LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
Autorzy:
Min JH; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Lee MW; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea. .; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea. .
Rhim H; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Han S; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Song KD; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Kang TW; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Jeong WK; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Cha DI; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.
Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim K; Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 525-537. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Radiofrequency Ablation*/methods
Catheter Ablation*/methods
Male ; Humans ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
Autorzy:
Wang Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Chen C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ge H; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of General Surgery, Ningbo Fourth Hospital, Ningbo, China.
Li E; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Cai Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Fu Q; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wu J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ye M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Cao W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wei X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Han X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun K; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan Q; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Huang W; Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wu L; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zeng Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Zhang Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2024 Mar 31; Vol. 585, pp. 216654. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Prospective Studies ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł:
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B.
Autorzy:
Kim TH; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Kim JH; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Yim HJ; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Seo YS; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
Yim SY; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
Lee YS; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Jung YK; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Yeon JE; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Um SH; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
Byun KS; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2024 Mar 15; Vol. 18 (2), pp. 305-315. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B, Chronic*
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Organophosphonates*
Guanine/*analogs & derivatives
Humans ; Tenofovir/therapeutic use ; Retrospective Studies ; Treatment Outcome ; Antiviral Agents/therapeutic use ; Adenine ; Alanine
Czasopismo naukowe
Tytuł:
FGF19-Based Mini Probe Targeting FGFR4 for Diagnosis and Surgical Navigation of Hepatocellular Carcinoma.
Autorzy:
Cai J; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Lian C; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.; Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining 314400, China.
Lu Z; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Shang Q; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Wang L; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Han Z; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Gu Y; State Key Laboratory of Natural Medicine, Department of Biomedical Engineering and Diagnostic Pharmacy, School of engineering, China Pharmaceutical University, Nanjing 211198, China.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Mar 14; Vol. 67 (5), pp. 3764-3777. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnosis
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Surgery, Computer-Assisted*
Humans ; Receptor, Fibroblast Growth Factor, Type 4 ; Fibroblast Growth Factors ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway.
Autorzy:
Pan T; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Li J; Department of Liver and Gall Surgery, The Third Affiliated Hospital of Wenzhou Medical University, 325200, Wenzhou, Zhejiang, China.
Zhang O; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Zhu Y; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Zhou H; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Ma M; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Yu Y; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China.
Lyu J; Department of Infectious Diseases, Lishui People's Hospital, 323000, Lishui, Zhejiang, China.
Chen Y; Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China. .
Xu L; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 12; Vol. 24 (1), pp. 334. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
RNA Processing, Post-Transcriptional*
Ribosomal Proteins*/genetics
Ribosomal Proteins*/metabolism
Animals ; Mice ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Epithelial-Mesenchymal Transition/genetics ; Focal Adhesion Protein-Tyrosine Kinases/genetics ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Gene Expression Regulation, Neoplastic ; NF-kappa B/metabolism ; Ribosomes/metabolism ; Ribosomes/pathology ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
S100A9 monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.
Autorzy:
Tu X; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.
Chen L; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Zheng Y; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Mu C; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.
Zhang Z; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Wang F; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China.; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Ren Y; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Duan Y; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China.
Zhang H; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Tong Z; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Liu L; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Sun X; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Zhao P; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Wang L; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310058, People's Republic of China.
Feng X; The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory of Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, People's Republic of China. .; Center for Life Sciences, Shaoxing Institute, Zhejiang University, Shaoxing, 321000, People's Republic of China. .
Fang W; Department of Medical Oncology, & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China. .
Liu X; ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, People's Republic of China. .; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 08; Vol. 43 (1), pp. 72. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/metabolism
Humans ; Animals ; Mice ; Monocytes/metabolism ; B7-H1 Antigen/metabolism ; T-Lymphocytes/metabolism ; Immunotherapy ; Tumor Microenvironment ; Calgranulin B/metabolism
Czasopismo naukowe
Tytuł:
ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
Autorzy:
Meng W; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Lu X; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Wang G; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China.
Xiao Q; Department of Blood Transfusion, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, Guangdong, 518108, P.R. China.
Gao J; Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, No. 11, Jixiang Road, Shiyan Street, Baoan District, Shenzhen, Guangdong, 518108, P.R. China. .
Pokaż więcej
Źródło:
Functional & integrative genomics [Funct Integr Genomics] 2024 Mar 08; Vol. 24 (2), pp. 53. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Liver Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Hep G2 Cells ; Glycolysis ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Fructose-Bisphosphate Aldolase/genetics ; Fructose-Bisphosphate Aldolase/metabolism
Czasopismo naukowe
Tytuł:
An AgPd NP-based lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein.
Autorzy:
Jiang S; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Chen Y; Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Liang J; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Xiao H; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Lin M; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Cui X; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Zhao S; Department of Pharmaceutical Engineering, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, People's Republic of China. .
Pokaż więcej
Źródło:
Analytical methods : advancing methods and applications [Anal Methods] 2024 Mar 07; Vol. 16 (10), pp. 1508-1514. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/pathology
Humans ; alpha-Fetoproteins ; Biomarkers, Tumor ; Glycocholic Acid ; Immunoassay/methods
Czasopismo naukowe
Tytuł:
Drug-Loaded Tumor-Derived Microparticles Elicit CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma.
Autorzy:
Chen Y; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Zhang Y; Hubei Engineering Research Center of Tumor-Targeted Biochemotherapy, Wuhan, 430030, People's Republic of China.
Wang J; Department of Hepatobiliary Surgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, People's Republic of China.
Cai X; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Chen J; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Min X; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Xu Y; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Qin Q; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Wan C; Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Pokaż więcej
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2024 Mar 06; Vol. 19, pp. 2227-2239. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Cancer Vaccines*
Humans ; Animals ; Mice ; Doxorubicin ; CD8-Positive T-Lymphocytes ; Tumor Microenvironment ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
Autorzy:
Zhao J; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.
Dai W; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Zhan L; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Lei L; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.
Jin Q; MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
Wang J; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.; Department of Colorectal Surgery and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Tang Z; Department of Surgery, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu 322000, China.; Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Mar 06; Vol. 16 (9), pp. 11289-11304. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Prodrugs*/pharmacology
Humans ; Tirapazamine/pharmacology ; Sorafenib/pharmacology ; Liposomes ; Hypoxia/drug therapy ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Liensinine, a Novel and Food-Derived Compound, Exerts Potent Antihepatoma Efficacy via Inhibiting the Kv10.1 Channel.
Autorzy:
Ma B; State Key Laboratory of Reliability and Intelligence of Electrical Equipment, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Electromagnetic Field and Electrical Apparatus Reliability of Hebei Province, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Shi S; Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin 300072, China.
Guo W; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Zhang H; Department of Pharmacology, Hebei Medical University, Shijiazhuang 050017, China.
Zhao Z; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
An H; State Key Laboratory of Reliability and Intelligence of Electrical Equipment, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Electromagnetic Field and Electrical Apparatus Reliability of Hebei Province, Hebei University of Technology, Tianjin 300401, China.; Key Laboratory of Molecular Biophysics, Hebei Province, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.
Pokaż więcej
Źródło:
Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Mar 06; Vol. 72 (9), pp. 4689-4702. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Isoquinolines*
Phenols*
Humans ; Ether-A-Go-Go Potassium Channels/chemistry ; Ether-A-Go-Go Potassium Channels/metabolism ; Carcinogenesis/metabolism
Czasopismo naukowe
Tytuł:
Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells.
Autorzy:
Jiao W; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Wen N; School of Science and Chemical Engineering, Ningxia Institute of Science and Technology, Shizuishan, Ningxia 753000, China.
Wang S; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Zhou G; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Lu Q; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Su Z; School of materials, Sun Yat-Sen University, Shen Zhen, Guangdong 529406, China.
Wang X; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Hu S; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Xie Y; Department of Hematology and Rheumatology, Qinghai Provincial People's Hospital, 2 Gonghe Road, Xining, Qinghai 810007, China.
Zhang N; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Liu X; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Province Center for Regenerative Medicine and Surgery Engineering Research, Shaanxi Provincial Key Laboratory of Magnetic Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. .; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.
Pokaż więcej
Źródło:
Journal of materials chemistry. B [J Mater Chem B] 2024 Mar 06; Vol. 12 (10), pp. 2628-2638. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/therapy
Liver Neoplasms*/pathology
Hyperthermia, Induced*/methods
Mice ; Animals ; Magnetics ; Magnetic Phenomena ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
Autorzy:
Jantaravinid J; Center of Excellence in Bioactive Resources for Innovative Clinical Applications, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.
Tirawanchai N; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Ampawong S; Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6, Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
Kengkoom K; Research and Academic Support Office, National Laboratory Animal Center, Mahidol University, 999, Salaya, Puttamonthon, Nakorn Pathom, 73170, Thailand.
Somkasetrin A; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, 2, Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Nakhonsri V; National Biobank of Thailand (NBT), National Science and Technology Development Agency (NSTDA), 144 Innovation Cluster 2 Building (INC) Tower A, Thailand Science Park, Khlong Nueng, Khlong Luang District, Pathum Thani, 12120, Thailand.
Aramwit P; Center of Excellence in Bioactive Resources for Innovative Clinical Applications, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand. .; The Academy of Science, The Royal Society of Thailand, Dusit, Bangkok, 10330, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 05; Vol. 14 (1), pp. 5455. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Sericins*/pharmacology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Humans ; TNF Receptor-Associated Factor 6 ; Gene Expression Profiling ; Apolipoproteins B
Czasopismo naukowe
Tytuł:
Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.
Autorzy:
Zhao T; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.; Henan International Joint Laboratory of Immunity and Targeted Therapy for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Wei P; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.; Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
Zhang C; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhou S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Liang L; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Guo S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Yin Z; The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, China.
Cheng S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Gan Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Xia Y; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhang Y; Department of Oncology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Guo S; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Zhong J; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Yang Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Tu F; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Wang Q; Department of Gynecology, Xinxiang Central Hospital, Xinxiang, China.; The Fourth Clinical College, Xinxiang Medical University, Xinxiang, China.
Bai J; Department of Gynecology, Xinxiang Central Hospital, Xinxiang, China.; The Fourth Clinical College, Xinxiang Medical University, Xinxiang, China.
Ren F; Henan International Joint Laboratory of Immunity and Targeted Therapy for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Feng Z; Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Jia H; Xinxiang Engineering Technology Research Center of immune checkpoint drug for Liver-Intestinal Tumors, Xinxiang Medical University, Xinxiang, China.
Pokaż więcej
Źródło:
ELife [Elife] 2024 Mar 05; Vol. 12. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/radiotherapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/radiotherapy
Nitrofurans*
Animals ; Mice ; B7-H1 Antigen ; Hydroxybenzoates
Czasopismo naukowe
Tytuł:
Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Autorzy:
Liang Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Zhong D; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Zhang Z; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Department of Hepatobiliary-Pancreatic and Hernia Surgery, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430033, China.
Su Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Yan S; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Lai C; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Yao Y; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Shi Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China.
Huang X; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. .; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China. .; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China. .
Shang J; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. .; Department of Hepatobiliary-Pancreatic Surgery, Cell Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China. .; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province & Organ Transplant Research Institute, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, West Second Section, First Ring Road, Qingyang District, Chengdu, 610072, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 04; Vol. 24 (1), pp. 291. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/surgery
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/surgery
Humans ; Hepatitis B virus ; DNA, Viral ; Prognosis ; Antiviral Agents/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies